Literature DB >> 11420117

NADH oxidase activity (NOX) and enlargement of HeLa cells oscillate with two different temperature-compensated period lengths of 22 and 24 minutes corresponding to different NOX forms.

S Wang1, R Pogue, D M Morré, D J Morré.   

Abstract

NOX proteins are cell surface-associated and growth-related hydroquinone (NADH) oxidases with protein disulfide-thiol interchange activity. A defining characteristic of NOX proteins is that the two enzymatic activities alternate to generate a regular period length of about 24 min. HeLa cells exhibit at least two forms of NOX. One is tumor-associated (tNOX) and is inhibited by putative quinone site inhibitors (e.g., capsaicin or the antitumor sulfonylurea, LY181984). Another is constitutive (CNOX) and refractory to inhibition. The periodic alternation of activities and drug sensitivity of the NADH oxidase activity observed with intact HeLa cells was retained in isolated plasma membranes and with the solubilized and partially purified enzyme. At least two activities were present. One had a period length of 24 min and the other had a period length of 22 min. The lengths of both the 22 and the 24 min periods were temperature compensated (approximately the same when measured at 17, 27 or 37 degrees C) whereas the rate of NADH oxidation approximately doubled with each 10 degrees C rise in temperature. The rate of increase in cell area of HeLa cells when measured by video-enhanced light microscopy also exhibited a complex period of oscillations reflective of both 22 and 24 min period lengths. The findings demonstrate the presence of a novel oscillating NOX activity at the surface of cancer cells with a period length of 22 min in addition to the constitutive NOX of non-cancer cells and tissues with a period length of 24 min.

Entities:  

Keywords:  NASA Discipline Cell Biology; Non-NASA Center

Mesh:

Substances:

Year:  2001        PMID: 11420117     DOI: 10.1016/s0167-4889(01)00107-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Essential role of copper in the activity and regular periodicity of a recombinant, tumor-associated, cell surface, growth-related and time-keeping hydroquinone (NADH) oxidase with protein disulfide-thiol interchange activity (ENOX2).

Authors:  Xiaoyu Tang; P-J Chueh; Ziying Jiang; Sara Layman; Berdine Martin; Chinpal Kim; Dorothy M Morré; D James Morré
Journal:  J Bioenerg Biomembr       Date:  2010-10-05       Impact factor: 2.945

2.  Structural changes revealed by Fourier transform infrared and circular dichroism spectroscopic analyses underlie tNOX periodic oscillations.

Authors:  Chinpal Kim; Sara Layman; Dorothy M Morré; D James Morré
Journal:  Dose Response       Date:  2006-05-01       Impact factor: 2.658

3.  Spectroscopic Analyses of Oscillations in ECTO-NOX-Catalyzed Oxidation of NADH.

Authors:  D James Morré; Dorothy M Morré
Journal:  Nonlinearity Biol Toxicol Med       Date:  2003-07

4.  Decomposition Analyses Applied to a Complex Ultradian Biorhythm: The Oscillating NADH Oxidase Activity of Plasma Membranes Having a Potential Time-Keeping (Clock) Function.

Authors:  Ken Foster; Nasim Anwar; Rhea Pogue; Dorothy M Morré; T W Keenan; D James Morré
Journal:  Nonlinearity Biol Toxicol Med       Date:  2003-01

5.  Periodic fluctuations in oxygen consumption comparing HeLa (cancer) and CHO (non-cancer) cells and response to external NAD(P)+/NAD(P)H.

Authors:  John Orczyk; Dorothy M Morré; D James Morré
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

Review 6.  Oscillatory serotonin function in depression.

Authors:  Ronald M Salomon; Ronald L Cowan
Journal:  Synapse       Date:  2013-05-21       Impact factor: 2.562

7.  Role of Rac1-dependent NADPH oxidase in the growth of pancreatic cancer.

Authors:  J Du; J Liu; B J Smith; M S Tsao; J J Cullen
Journal:  Cancer Gene Ther       Date:  2010-10-29       Impact factor: 5.987

8.  ENOX2 target for the anticancer isoflavone ME-143.

Authors:  D James Morré; Theodore Korty; Christiaan Meadows; Laura M C Ades; Dorothy M Morré
Journal:  Oncol Res       Date:  2014       Impact factor: 5.574

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.